Breakthrough anti-HIV gel: Factfile

Following is a factfile on an anti-HIV vaginal gel whose test results, unveiled at the International AIDS Conference in Vienna, have sparked the biggest excitement in years in the war on AIDS:

WHAT IS IT?

A microbicide cream inserted in the vagina which aims to shield a woman against HIV in semen. Volunteers in South Africa who used the formula over 30 months had a 39-percent lower risk overall of HIV infection compared with counterparts who used a dummy lookalike gel.

WHY ALL THE FUSS?

After two decades' effort, this the first proof that a microbicide can offer significant protection against the human immunodeficiency virus (HIV). Some veterans compare the news to the advent in 1996 of the anti-HIV drug "cocktail" and the 2006 discovery that circumcision more than halves the infection risk for men.

WHY WOULD IT HELP?

A microbicide would join condoms and circumcision in the arsenal for preventing the spread of HIV. Each year, some 2.7 million people become infected with HIV. Treatment, a lifelong affair in the absence of a cure, is now a huge and possibly unsustainable financial burden. Microbicides would especially help women in sub-Saharan Africa, exposed to coercive sex with an infected partner who refuses to wear a condom.

IS THE MICROBICIDE AVAILABLE?

No. The results are only for a second stage in a long, three-phase process in which new drugs are vetted for safety and efficacy. Third phases typically take two or three years. Health watchdogs then pore over the data before deciding whether to licence a product. The gel, if approved, could cost around 20 US cents per application, according to some estimates.

WHAT'S IN THE GEL?

It contains a one-percent concentration of tenofovir, a frontline drug in the combination therapy to treat people already infected with HIV. Antiretrovirals work by preventing HIV from reproducing in CD4 immune cells. Previously tested gels, which have not used antiretrovirals, have had negligible protection or even boosted the risk of infection.

IS THE GEL A GOOD ENOUGH SHIELD?

Protection of 39 percent may not be high enough for watchdogs in rich countries, where 80 percent is a likelier benchmark. But, coupled to other prevention measures, it could be acceptable in countries in sub-Sahara Africa where two-thirds of infections occur. In South Africa alone, a gel with such effectiveness would save 1.3 million new infections and avert 800,000 deaths over 20 years, the researchers say.

WHO TESTED THE GEL?

The Centre for the AIDS Programme of Research in South Africa, or CAPRISA. The trial, called CAPRISA 004, was tested among 889 sexually active, HIV-uninfected women living in urban and rural settings. The investigation was framed by tough ethical guidelines, in which the women were regularly advised on the risks, counselled on safe sex and given access to condoms.

WHAT HAPPENED IN THE TRIAL?

Half the volunteers were given the gel and the other the placebo. They were told to use the product within 12 hours before sex, and as soon as possible afterwards, but also within 12 hours. Each month, they were monitored for HIV infection, quizzed about their sexual activity and given more counselling. Women who became infected or pregnant were withdrawn from the trial. In the placebo group, 60 became infected, while the tally in the gel group was 38.

WHAT ABOUT SIDE EFFECTS?

The gel was found to be safe, which historically has been a big worry in microbicide research. Also, there was no sign that a woman who became infected after using the gel was resistant to tenofovir. This too is a relief, given concerns that on-again, off-again use could help HIV become immune to this important drug.

WHY ARE EXPERTS CAUTIOUS?

While hailing the Phase IIb results, specialists are awaiting the outcome of the third phase before popping the champagne. Among the questions is how the gel was used. Women who used it most consistently had a protection of 54 percent; those who used it least consistently, just 28 percent. Effectiveness fell markedly over the course of trial, possibly because use of the microbicide declined among some women.

WHAT ABOUT THE FUTURE?

If the CAPRISA 004 data are confirmed, this could be just the start of an extraordinary tale for microbicides. Scientists will want to see whether different antiretrovirals or ways of using the gel - perhaps through a slow-release vaginal ring - could boost protection. Many are inspired by the slow start but ultimately glittering success of HIV drugs, now a lifeline for 5.2 million people. Another avenue of exploration is whether the microbicide is effective in anal intercourse, where the statistical risk of infection is 10 times higher than in vaginal sex.

Sources: CAPRISA IIb data, published in US journal science; CAPRISA researchers; interviews and conferences with non-CAPRISA specialists at 18th International AIDS Conference.

ri/lt

 

Life and Style
ebookNow available in paperback
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Guru Careers: Software Developer / C# Developer

    £40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

    Guru Careers: Software Developer

    £35 - 40k + Benefits: Guru Careers: We are seeking a Software Developer (JavaS...

    SThree: Trainee Recruitment Consultant / Resourcer

    £18000 - £23000 per annum + Commission: SThree: As a Trainee Recruitment Consu...

    Ashdown Group: UI Developer - (UI, HTML, CSS, JavaScript, AngularJS)

    £25000 - £40000 per annum: Ashdown Group: UI Developer - (UI, JavaScript, HTML...

    Day In a Page

    Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

    Sun, sex and an anthropological study

    One academic’s summer of hell in Magaluf
    From Shakespeare to Rising Damp... to Vicious

    Frances de la Tour's 50-year triumph

    'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
    'That Whitsun, I was late getting away...'

    Ian McMillan on the Whitsun Weddings

    This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
    Kathryn Williams explores the works and influences of Sylvia Plath in a new light

    Songs from the bell jar

    Kathryn Williams explores the works and influences of Sylvia Plath
    How one man's day in high heels showed him that Cannes must change its 'no flats' policy

    One man's day in high heels

    ...showed him that Cannes must change its 'flats' policy
    Is a quiet crusade to reform executive pay bearing fruit?

    Is a quiet crusade to reform executive pay bearing fruit?

    Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
    The King David Hotel gives precious work to Palestinians - unless peace talks are on

    King David Hotel: Palestinians not included

    The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
    More people moving from Australia to New Zealand than in the other direction for first time in 24 years

    End of the Aussie brain drain

    More people moving from Australia to New Zealand than in the other direction for first time in 24 years
    Meditation is touted as a cure for mental instability but can it actually be bad for you?

    Can meditation be bad for you?

    Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
    Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

    Australia's first-ever Eurovision entrant

    Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
    Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

    Laughter, but no tears, as Letterman takes his bow after 33 years

    Veteran talkshow host steps down to plaudits from four presidents
    Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

    Hozier's 'blasphemous' song takes Novello award

    Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
    Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

    Join the tequila gold rush

    The spirit has gone from a cheap shot to a multi-billion pound product
    12 best statement wallpapers

    12 best statement wallpapers

    Make an impact and transform a room with a conversation-starting pattern
    Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

    Paul Scholes column

    Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?